Depressive symptoms during the menopausal transition

The Study of Women's Health Across the Nation (SWAN)

Joyce T. Bromberger, Karen A. Matthews, Laura L. Schott, Sarah Brockwell, Nancy E. Avis, Howard M. Kravitz, Susan A. Everson-Rose, Ellen B. Gold, Mary Fran Sowers, John F. Randolph

Research output: Contribution to journalArticle

246 Citations (Scopus)

Abstract

Background: The influence of menopausal status on depressive symptoms is unclear in diverse ethnic groups. This study examined the longitudinal relationship between changes in menopausal status and the risk of clinically relevant depressive symptoms and whether the relationship differed according to initial depressive symptom level. Methods: 3302 African American, Chinese, Hispanic, Japanese, and White women, aged 42-52 years at entry into the Study of Women's Health Across the Nation (SWAN), a community-based, multisite longitudinal observational study, were evaluated annually from 1995 through 2002. Random effects multiple logistic regression analyses were used to determine the relationship between menopausal status and prevalence of low and high depressive symptom scores (CES-D < 16 or ≥ 16) over 5 years. Results: At baseline, 23% of the sample had elevated CES-D scores. A woman was more likely to report CES-D ≥ 16 when she was early peri-, late peri-, postmenopausal or currently/formerly using hormone therapy (HT), relative to when she was premenopausal (OR range 1.30 to 1.71). Effects were somewhat stronger for women with low CES-D scores at baseline. Health and psychosocial factors increased the odds of having a high CES-D and in some cases, were more important than menopausal status. Limitations: We used a measure of current depressive symptoms rather than a diagnosis of clinical depression. Thus, we can only make conclusions about symptoms current at annual assessments. Conclusion: Most midlife women do not experience high depressive symptoms. Those that do are more likely to experience high depressive symptom levels when perimenopausal or postmenopausal than when premenopausal, independent of factors such as difficulty paying for basics, negative attitudes, poor perceived health, and stressful events.

Original languageEnglish (US)
Pages (from-to)267-272
Number of pages6
JournalJournal of Affective Disorders
Volume103
Issue number1-3
DOIs
StatePublished - Nov 1 2007

Fingerprint

Women's Health
Depression
Longitudinal Studies
Health
Hispanic Americans
Ethnic Groups
African Americans
Observational Studies
Logistic Models
Regression Analysis
Hormones
Psychology

Keywords

  • CES-D
  • Depressive symptoms
  • Longitudinal
  • Menopause

Cite this

Bromberger, J. T., Matthews, K. A., Schott, L. L., Brockwell, S., Avis, N. E., Kravitz, H. M., ... Randolph, J. F. (2007). Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN). Journal of Affective Disorders, 103(1-3), 267-272. https://doi.org/10.1016/j.jad.2007.01.034

Depressive symptoms during the menopausal transition : The Study of Women's Health Across the Nation (SWAN). / Bromberger, Joyce T.; Matthews, Karen A.; Schott, Laura L.; Brockwell, Sarah; Avis, Nancy E.; Kravitz, Howard M.; Everson-Rose, Susan A.; Gold, Ellen B.; Sowers, Mary Fran; Randolph, John F.

In: Journal of Affective Disorders, Vol. 103, No. 1-3, 01.11.2007, p. 267-272.

Research output: Contribution to journalArticle

Bromberger, JT, Matthews, KA, Schott, LL, Brockwell, S, Avis, NE, Kravitz, HM, Everson-Rose, SA, Gold, EB, Sowers, MF & Randolph, JF 2007, 'Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN)', Journal of Affective Disorders, vol. 103, no. 1-3, pp. 267-272. https://doi.org/10.1016/j.jad.2007.01.034
Bromberger, Joyce T. ; Matthews, Karen A. ; Schott, Laura L. ; Brockwell, Sarah ; Avis, Nancy E. ; Kravitz, Howard M. ; Everson-Rose, Susan A. ; Gold, Ellen B. ; Sowers, Mary Fran ; Randolph, John F. / Depressive symptoms during the menopausal transition : The Study of Women's Health Across the Nation (SWAN). In: Journal of Affective Disorders. 2007 ; Vol. 103, No. 1-3. pp. 267-272.
@article{f67da745135d442b99f2d14e3b6a6a99,
title = "Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN)",
abstract = "Background: The influence of menopausal status on depressive symptoms is unclear in diverse ethnic groups. This study examined the longitudinal relationship between changes in menopausal status and the risk of clinically relevant depressive symptoms and whether the relationship differed according to initial depressive symptom level. Methods: 3302 African American, Chinese, Hispanic, Japanese, and White women, aged 42-52 years at entry into the Study of Women's Health Across the Nation (SWAN), a community-based, multisite longitudinal observational study, were evaluated annually from 1995 through 2002. Random effects multiple logistic regression analyses were used to determine the relationship between menopausal status and prevalence of low and high depressive symptom scores (CES-D < 16 or ≥ 16) over 5 years. Results: At baseline, 23{\%} of the sample had elevated CES-D scores. A woman was more likely to report CES-D ≥ 16 when she was early peri-, late peri-, postmenopausal or currently/formerly using hormone therapy (HT), relative to when she was premenopausal (OR range 1.30 to 1.71). Effects were somewhat stronger for women with low CES-D scores at baseline. Health and psychosocial factors increased the odds of having a high CES-D and in some cases, were more important than menopausal status. Limitations: We used a measure of current depressive symptoms rather than a diagnosis of clinical depression. Thus, we can only make conclusions about symptoms current at annual assessments. Conclusion: Most midlife women do not experience high depressive symptoms. Those that do are more likely to experience high depressive symptom levels when perimenopausal or postmenopausal than when premenopausal, independent of factors such as difficulty paying for basics, negative attitudes, poor perceived health, and stressful events.",
keywords = "CES-D, Depressive symptoms, Longitudinal, Menopause",
author = "Bromberger, {Joyce T.} and Matthews, {Karen A.} and Schott, {Laura L.} and Sarah Brockwell and Avis, {Nancy E.} and Kravitz, {Howard M.} and Everson-Rose, {Susan A.} and Gold, {Ellen B.} and Sowers, {Mary Fran} and Randolph, {John F.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.jad.2007.01.034",
language = "English (US)",
volume = "103",
pages = "267--272",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier B.V.",
number = "1-3",

}

TY - JOUR

T1 - Depressive symptoms during the menopausal transition

T2 - The Study of Women's Health Across the Nation (SWAN)

AU - Bromberger, Joyce T.

AU - Matthews, Karen A.

AU - Schott, Laura L.

AU - Brockwell, Sarah

AU - Avis, Nancy E.

AU - Kravitz, Howard M.

AU - Everson-Rose, Susan A.

AU - Gold, Ellen B.

AU - Sowers, Mary Fran

AU - Randolph, John F.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Background: The influence of menopausal status on depressive symptoms is unclear in diverse ethnic groups. This study examined the longitudinal relationship between changes in menopausal status and the risk of clinically relevant depressive symptoms and whether the relationship differed according to initial depressive symptom level. Methods: 3302 African American, Chinese, Hispanic, Japanese, and White women, aged 42-52 years at entry into the Study of Women's Health Across the Nation (SWAN), a community-based, multisite longitudinal observational study, were evaluated annually from 1995 through 2002. Random effects multiple logistic regression analyses were used to determine the relationship between menopausal status and prevalence of low and high depressive symptom scores (CES-D < 16 or ≥ 16) over 5 years. Results: At baseline, 23% of the sample had elevated CES-D scores. A woman was more likely to report CES-D ≥ 16 when she was early peri-, late peri-, postmenopausal or currently/formerly using hormone therapy (HT), relative to when she was premenopausal (OR range 1.30 to 1.71). Effects were somewhat stronger for women with low CES-D scores at baseline. Health and psychosocial factors increased the odds of having a high CES-D and in some cases, were more important than menopausal status. Limitations: We used a measure of current depressive symptoms rather than a diagnosis of clinical depression. Thus, we can only make conclusions about symptoms current at annual assessments. Conclusion: Most midlife women do not experience high depressive symptoms. Those that do are more likely to experience high depressive symptom levels when perimenopausal or postmenopausal than when premenopausal, independent of factors such as difficulty paying for basics, negative attitudes, poor perceived health, and stressful events.

AB - Background: The influence of menopausal status on depressive symptoms is unclear in diverse ethnic groups. This study examined the longitudinal relationship between changes in menopausal status and the risk of clinically relevant depressive symptoms and whether the relationship differed according to initial depressive symptom level. Methods: 3302 African American, Chinese, Hispanic, Japanese, and White women, aged 42-52 years at entry into the Study of Women's Health Across the Nation (SWAN), a community-based, multisite longitudinal observational study, were evaluated annually from 1995 through 2002. Random effects multiple logistic regression analyses were used to determine the relationship between menopausal status and prevalence of low and high depressive symptom scores (CES-D < 16 or ≥ 16) over 5 years. Results: At baseline, 23% of the sample had elevated CES-D scores. A woman was more likely to report CES-D ≥ 16 when she was early peri-, late peri-, postmenopausal or currently/formerly using hormone therapy (HT), relative to when she was premenopausal (OR range 1.30 to 1.71). Effects were somewhat stronger for women with low CES-D scores at baseline. Health and psychosocial factors increased the odds of having a high CES-D and in some cases, were more important than menopausal status. Limitations: We used a measure of current depressive symptoms rather than a diagnosis of clinical depression. Thus, we can only make conclusions about symptoms current at annual assessments. Conclusion: Most midlife women do not experience high depressive symptoms. Those that do are more likely to experience high depressive symptom levels when perimenopausal or postmenopausal than when premenopausal, independent of factors such as difficulty paying for basics, negative attitudes, poor perceived health, and stressful events.

KW - CES-D

KW - Depressive symptoms

KW - Longitudinal

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=34347361287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347361287&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2007.01.034

DO - 10.1016/j.jad.2007.01.034

M3 - Article

VL - 103

SP - 267

EP - 272

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-3

ER -